Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs
- PMID: 20189103
- PMCID: PMC2858875
- DOI: 10.1016/j.chembiol.2010.01.010
Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs
Abstract
PI3Kdelta and PI3Kgamma regulate immune cell signaling, while the related PI3Kalpha and PI3Kbeta regulate cell survival and metabolism. Selective inhibitors of PI3Kdelta/gamma represent a potential class of anti-inflammatory agents lacking the antiproliferative effects associated with PI3Kalpha/beta inhibition. Here we report the discovery of PI3Kdelta/gamma inhibitors that display up to 1000-fold selectivity over PI3Kalpha/beta and evaluate these compounds in a high-content inflammation assay using mixtures of primary human cells. We find selective inhibition of only PI3Kdelta is weakly anti-inflammatory, but PI3Kdelta/gamma inhibitors show superior inflammatory marker suppression through suppression of lipopolysaccharide-induced TNFalpha production and T cell activation. Moreover, PI3Kdelta/gamma inhibition yields an anti-inflammatory signature distinct from pan-PI3K inhibition and known anti-inflammatory drugs, yet bears striking similarities to glucocorticoid receptor agonists. These results highlight the potential of selectively designing drugs that target kinases with shared biological function.
Copyright 2010 Elsevier Ltd. All rights reserved.
Figures





References
-
- Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan A, Tkaczyk C, Kuehn N, Gray A, Giddings J, Peskett E, et al. Essential role for the p110 delta phosphoinositide 3-kinase in the allergic response. Nature. 2004;431:1007–1011. - PubMed
-
- Backhouse C, Engler C, English J. Naproxen Sodium and Indomethacin in Acute Musculoskeletal Disorders. Rheumatol Rehabil. 1980;19:113–119. - PubMed
-
- Berg E, Kunkel E, Hytopoulos E, Plavec I. Characterization of compound mechanisms and secondary activities by BioMAP analysis. Journal of Pharmacological and Toxicological Methods. 2006;53:67–74. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous